Cargando…
Intramyocardial transplantation of cardiac mesenchymal stem cells reduces myocarditis in a model of chronic Chagas disease cardiomyopathy
INTRODUCTION: New therapeutic options are necessary for patients with chronic Chagas disease, a leading cause of heart failure in Latin American countries. Stem cell therapy focused on improving cardiac function is a promising approach for treating heart disease. Here, we evaluated the therapeutic e...
Autores principales: | Silva, Daniela Nascimento, de Freitas Souza, Bruno Solano, Azevedo, Carine Machado, Vasconcelos, Juliana Fraga, Carvalho, Rejane Hughes, Soares, Milena Botelho Pereira, dos Santos, Ricardo Ribeiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229984/ https://www.ncbi.nlm.nih.gov/pubmed/24984860 http://dx.doi.org/10.1186/scrt470 |
Ejemplares similares
-
Galectin-3 Knockdown Impairs Survival, Migration, and Immunomodulatory Actions of Mesenchymal Stromal Cells in a Mouse Model of Chagas Disease Cardiomyopathy
por: Souza, Bruno Solano de Freitas, et al.
Publicado: (2017) -
Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy
por: Vasconcelos, Juliana Fraga, et al.
Publicado: (2017) -
Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy
por: Santos, Emanuelle de Souza, et al.
Publicado: (2021) -
Lack of association between serum syndecan-4, myocardial fibrosis and ventricular dysfunction in subjects with chronic Chagas disease
por: Larocca, Ticiana Ferreira, et al.
Publicado: (2017) -
Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)